TP53 and cancer: Besides, compared with the patients with low-risk scores, the genes with significantly higher expression in the high-risk score group were mainly concentrated in pathways involved in cancer, the MAPK signaling pathway, and the P53 signaling pathway (Supplementary Figure 22C).